In the Media

Sonia Vallabh, Director of Prion Therapeutic Science at the Broad Institute of MIT and Harvard, speaks to Nature’s Josie Glausiusz about her journey co-leading an initiative to develop preventive drugs for prion disease, a rare, lethal neurodegenerative disease that is caused by misfolded proteins that kill neurons. “In pre-symptomatic people at risk, if we can lower the amount of normal protein, I’m hoping we can delay or even prevent the formation of the first misfolded prion,” says Vallabh.